CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE

All Clinical Trials for CLINDAMYCIN PHOSPHATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00160394 ↗	Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris	Completed	GlaxoSmithKline	Phase 4	2004-12-01	Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.
NCT00160394 ↗	Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris	Completed	Stiefel, a GSK Company	Phase 4	2004-12-01	Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.
NCT00219570 ↗	Dalacin-T Gel Post Approval Study	Completed	Acronet	Phase 4	2005-01-01	To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.
NCT00219570 ↗	Dalacin-T Gel Post Approval Study	Completed	Bellsystem24 , Inc.	Phase 4	2005-01-01	To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.
NCT00219570 ↗	Dalacin-T Gel Post Approval Study	Completed	Mitsubishi Kagaku Bio-Clinical Laboratories, inc	Phase 4	2005-01-01	To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.
NCT00219570 ↗	Dalacin-T Gel Post Approval Study	Completed	Parexel	Phase 4	2005-01-01	To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel.

Clinical Trial Conditions for CLINDAMYCIN PHOSPHATE

Condition Name

Condition Name for CLINDAMYCIN PHOSPHATE
Intervention	Trials
Acne Vulgaris	18
Bacterial Vaginosis	3
Acne	2
Glioblastoma	1

Condition MeSH

Condition MeSH for CLINDAMYCIN PHOSPHATE
Intervention	Trials
Acne Vulgaris	20
Vaginosis, Bacterial	3
Vaginal Diseases	2
Communicable Diseases	1

Clinical Trial Locations for CLINDAMYCIN PHOSPHATE

Trials by Country

Trials by Country for CLINDAMYCIN PHOSPHATE
Location	Trials
United States	90
India	19
China	10
Russian Federation	4
Puerto Rico	2

Trials by US State

Trials by US State for CLINDAMYCIN PHOSPHATE
Location	Trials
Pennsylvania	6
New York	6
Texas	5
Florida	5
California	5

Clinical Trial Progress for CLINDAMYCIN PHOSPHATE

Clinical Trial Phase

Clinical Trial Phase for CLINDAMYCIN PHOSPHATE
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	9
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for CLINDAMYCIN PHOSPHATE
Clinical Trial Phase	Trials
Completed	25
Unknown status	4
Recruiting	1

Clinical Trial Sponsors for CLINDAMYCIN PHOSPHATE

Sponsor Name

Sponsor Name for CLINDAMYCIN PHOSPHATE
Sponsor	Trials
GlaxoSmithKline	6
Stiefel, a GSK Company	4
Watson Laboratories, Inc.	2

Sponsor Type

Sponsor Type for CLINDAMYCIN PHOSPHATE
Sponsor	Trials
Industry	35
Other	16